Form 8-K - Current report:
SEC Accession No. 0000950170-21-000411
Filing Date
2021-06-30
Accepted
2021-06-30 13:42:10
Documents
16
Period of Report
2021-06-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cmpx-20210625.htm   iXBRL 8-K 67119
2 EX-10.1 cmpx-20210625ex10_1.htm EX-10.1 99891
3 GRAPHIC img204111032_2.jpg GRAPHIC 16196
4 GRAPHIC img204111032_0.jpg GRAPHIC 16196
5 GRAPHIC img204111032_1.jpg GRAPHIC 16196
  Complete submission text file 0000950170-21-000411.txt   361642

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cmpx-20210625_pre.xml EX-101.PRE 10402
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cmpx-20210625_lab.xml EX-101.LAB 14046
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cmpx-20210625.xsd EX-101.SCH 2474
9 EXTRACTED XBRL INSTANCE DOCUMENT cmpx-20210625_htm.xml XML 4888
Mailing Address 80 GUEST STREET BOSTON MA 02135
Business Address 80 GUEST STREET BOSTON MA 02135 617-500-8099
Compass Therapeutics, Inc. (Filer) CIK: 0001738021 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39696 | Film No.: 211061324
SIC: 2836 Biological Products, (No Diagnostic Substances)